As of Mar 27
| +0.018 / +5.77%|
The 1 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +203.03% increase from the last price of 0.33.
The current consensus among 2 polled investment analysts is to Buy stock in InspireMD Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.